InnoCan Secures FDA CVM Waiver for LPT-CBD Drug
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
Indianapolis, USA | January 22, 2026 — Elanco Animal Health, a global leader in veterinary pharmaceuticals and animal health...
DULUTH, Georgia | January 19, 2026 — Boehringer Ingelheim announced that the U.S. Food and Drug Administration has granted...
